Key | % Net Assets |
---|---|
GlaxoSmithKline | 8.8% |
BP | 6.3% |
Royal Dutch Shell 'B' | 5.8% |
BT | 5.7% |
Other | 73.4% |
Name | % Net Assets |
---|---|
GlaxoSmithKline | 8.8% |
BP | 6.3% |
Royal Dutch Shell 'B' | 5.8% |
BT | 5.7% |
British Energy | 5.6% |
Vodafone | 4.7% |
AstraZeneca | 4.5% |
Imperial Tobacco | 4.4% |
Reynolds American | 4.1% |
British Airways | 4.0% |
Key | % Net Assets |
---|---|
Oil & Gas | 16.70% |
Financials | 14.30% |
Health Care | 13.30% |
Utilities | 12.60% |
Consumer Services | 11.80% |
Date | 03-Oct-2008 |
---|---|
NAV | 59.37p |
Currency | GBP |
Change | -0.30p |
% | -0.50% |
YTD change | 59.37p |
YTD % | n/a |
Fund Inception | 30/01/1998 |
---|---|
Fund Manager | Martin Walker |
TER | - |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £100 |
Savings | £20 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | -0.01 |
You are here: research